• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在连续血糖监测设备使用欠佳的情况下,连续血糖监测指标达到具有代表性的血糖结果所需的最短采样持续时间。

Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use.

作者信息

Akturk Halis K, Sakamoto Casey, Vigers Tim, Shah Viral N, Pyle Laura

机构信息

Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.

出版信息

J Diabetes Sci Technol. 2025 Mar;19(2):345-351. doi: 10.1177/19322968231200901. Epub 2023 Sep 25.

DOI:10.1177/19322968231200901
PMID:37747124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11874234/
Abstract

BACKGROUND

Two weeks of continuous glucose monitoring (CGM) sampling with >70% CGM use is recommended to accurately reflect 90 days of glycemic metrics. However, minimum sampling duration for CGM use <70% is not well studied. We investigated the minimum duration of CGM sampling required for each CGM metric to achieve representative glycemic outcomes for <70% CGM use over 90 days.

METHODS

Ninety days of CGM data were collected in 336 real-life CGM users with type 1 diabetes. CGM data were grouped in 5% increments of CGM use (45%-95%) over 90 days. For each CGM metric and each CGM use category, the correlation between the summary statistic calculated using each sampling period and all 90 days of data was determined using the squared value of the Spearmen correlation coefficient ().

RESULTS

For CGM use 45% to 95% over 90 days, minimum sampling period is 14 days for mean glucose, time in range (70-180 mg/dL), time >180 mg/dL, and time >250 mg/dL; 28 days for coefficient of variation, and 35 days for time <54 mg/dL. For time <70 mg/dL, 28 days is sufficient between 45 and 80% CGM use, while 21 days is required >80% CGM use.

CONCLUSION

We defined minimum sampling durations for all CGM metrics in suboptimal CGM use. CGM sampling of at least 14 days is required for >45% CGM use over 90 days to sufficiently reflect most of the CGM metrics. Assessment of hypoglycemia and coefficient of variation require a longer sampling period regardless of CGM use duration.

摘要

背景

建议进行两周的持续葡萄糖监测(CGM)采样,且CGM使用率>70%,以准确反映90天的血糖指标。然而,对于CGM使用率<70%时的最短采样持续时间研究不足。我们调查了在90天内CGM使用率<70%时,每种CGM指标实现代表性血糖结果所需的最短CGM采样持续时间。

方法

收集了336名1型糖尿病实际CGM使用者90天的CGM数据。CGM数据按90天内CGM使用率5%的增量分组(45%-95%)。对于每种CGM指标和每个CGM使用类别,使用斯皮尔曼相关系数()的平方值确定每个采样期计算的汇总统计量与所有90天数据之间的相关性。

结果

对于90天内CGM使用率为45%至95%的情况,平均血糖、血糖在目标范围内的时间(70-180mg/dL)、血糖>180mg/dL的时间以及血糖>250mg/dL的时间的最短采样期为14天;变异系数的最短采样期为28天,血糖<54mg/dL的时间的最短采样期为35天。对于血糖<70mg/dL,CGM使用率在45%至80%之间时28天就足够了,而CGM使用率>80%时需要21天。

结论

我们定义了次优CGM使用情况下所有CGM指标的最短采样持续时间。90天内CGM使用率>45%时,需要至少14天的CGM采样才能充分反映大多数CGM指标。无论CGM使用持续时间如何,低血糖评估和变异系数评估都需要更长的采样期。

相似文献

1
Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use.在连续血糖监测设备使用欠佳的情况下,连续血糖监测指标达到具有代表性的血糖结果所需的最短采样持续时间。
J Diabetes Sci Technol. 2025 Mar;19(2):345-351. doi: 10.1177/19322968231200901. Epub 2023 Sep 25.
2
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.14 天连续血糖监测采样评估 1 型糖尿病患者低血糖和血糖变异性的局限性。
Diabetes Technol Ther. 2024 Jul;26(7):503-508. doi: 10.1089/dia.2023.0476. Epub 2024 Feb 16.
3
Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.使用连续血糖监测系统研究血糖控制良好的 2 型糖尿病患者的血糖变异性。
J Assoc Physicians India. 2024 Jan;72(1):18-21. doi: 10.59556/japi.71.0441.
4
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.最佳连续血糖监测采样时长以评估长期血糖控制
Diabetes Technol Ther. 2018 Apr;20(4):314-316. doi: 10.1089/dia.2017.0455. Epub 2018 Mar 22.
5
Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.稳健确定最佳连续血糖监测干预长度以评估长期血糖控制。
Diabetes Technol Ther. 2021 Apr;23(4):314-319. doi: 10.1089/dia.2020.0387.
6
Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.使用连续血糖监测评估 1 型糖尿病患儿的长期血糖控制和血糖变异性:确定最佳采样持续时间。
Pediatr Diabetes. 2020 Dec;21(8):1485-1492. doi: 10.1111/pedi.13115. Epub 2020 Sep 28.
7
Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.妊娠期使用连续血糖监测的 1 型糖尿病女性的血糖、母婴结局 - 泵 vs 多次每日注射:一项观察性队列研究的二次分析。
Acta Obstet Gynecol Scand. 2021 May;100(5):927-933. doi: 10.1111/aogs.14039. Epub 2021 Jan 12.
8
Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis.韩国 1 型糖尿病患者的真实世界连续血糖监测数据:全国单一系统分析。
Diabetes Technol Ther. 2024 Jun;26(6):394-402. doi: 10.1089/dia.2023.0513. Epub 2024 Apr 26.
9
Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.用于估算血糖风险指数的连续血糖监测的最佳采样持续时间。
Diabetes Technol Ther. 2023 Feb;25(2):140-142. doi: 10.1089/dia.2022.0401. Epub 2022 Dec 2.
10
The Longer, the Better: Continuous Glucose Monitoring Use for ≥90% Is Superior to 70%-89% in Achieving Tighter Glycemic Outcomes in Children with Type 1 Diabetes.时间越长越好:1型糖尿病患儿连续血糖监测使用时间≥90%在实现更严格血糖控制结果方面优于70%-89%。
Diabetes Technol Ther. 2025 Apr;27(4):301-307. doi: 10.1089/dia.2024.0472. Epub 2025 Jan 6.

引用本文的文献

1
Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulation.连续血糖监测观察期与评估长期血糖调节时估计误差之间关系的量化。
BMJ Open Diabetes Res Care. 2025 Feb 26;13(1):e004768. doi: 10.1136/bmjdrc-2024-004768.
2
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study.不同指标的不同时间:预测1型糖尿病患者每日多次注射治疗期间间歇性扫描持续葡萄糖监测数据的90天情况。一项多中心真实世界研究的结果
J Diabetes Sci Technol. 2025 Jan 7:19322968241308564. doi: 10.1177/19322968241308564.
3
Do Metrics of Temporal Glycemic Variability Reveal Abnormal Glucose Rates of Change in Type 1 Diabetes?1型糖尿病患者的血糖波动时间指标能否揭示异常的血糖变化率?
J Diabetes Sci Technol. 2024 Nov 11:19322968241298248. doi: 10.1177/19322968241298248.

本文引用的文献

1
Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.实现 1 型糖尿病青少年达标时间的临床目标与治疗方式的相关性研究。
JAMA Netw Open. 2023 Feb 1;6(2):e230077. doi: 10.1001/jamanetworkopen.2023.0077.
2
Impact of Missing Data on the Accuracy of Glucose Metrics from Continuous Glucose Monitoring Assessed Over a 2-Week Period.连续血糖监测2周期间缺失数据对血糖指标准确性的影响
Diabetes Technol Ther. 2023 May;25(5):356-362. doi: 10.1089/dia.2022.0101.
3
International Consensus of Continuous Glucose Monitor Use in Pharmacological Clinical Trials in Diabetes.糖尿病药理临床试验中持续葡萄糖监测仪使用的国际共识
Diabetes Technol Ther. 2023 Apr;25(4):217-218. doi: 10.1089/dia.2023.0054. Epub 2023 Feb 17.
4
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.连续血糖监测及其临床试验指标:国际共识声明。
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6.
5
Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.用于估算血糖风险指数的连续血糖监测的最佳采样持续时间。
Diabetes Technol Ther. 2023 Feb;25(2):140-142. doi: 10.1089/dia.2022.0401. Epub 2022 Dec 2.
6
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.不同类型数据丢失对最佳连续血糖监测采样时间的影响。
Diabetes Technol Ther. 2022 Oct;24(10):749-753. doi: 10.1089/dia.2022.0093. Epub 2022 Jun 27.
7
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.经临床医生评估验证的用于连续血糖监测的低血糖和高血糖血糖风险指数(GRI)。
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. doi: 10.1177/19322968221085273. Epub 2022 Mar 29.
8
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study.1 型糖尿病诊断后一年内开始进行连续血糖监测与改善血糖结局相关:7 年随访研究。
Diabetes Care. 2022 Mar 1;45(3):750-753. doi: 10.2337/dc21-2004.
9
Comparison of Cgmanalysis, a Free Open-Source Continuous Glucose Monitoring Data Management and Analysis Software, with Commercially Available CGM Platforms: Data Standardization for Diabetes Technology Research.免费开源的连续血糖监测数据管理与分析软件Cgmanalysis与市售连续血糖监测平台的比较:糖尿病技术研究的数据标准化
Diabetes Technol Ther. 2022 Jan;24(1):54-60. doi: 10.1089/dia.2021.0200. Epub 2021 Dec 14.
10
Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.稳健确定最佳连续血糖监测干预长度以评估长期血糖控制。
Diabetes Technol Ther. 2021 Apr;23(4):314-319. doi: 10.1089/dia.2020.0387.